XML 31 R15.htm IDEA: XBRL DOCUMENT v3.26.1
Balance Sheet Components
6 Months Ended
Jun. 30, 2026
Balance Sheet Components  
Balance Sheet Components

8. Balance Sheet Components (in thousands)

June 30, 

December 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Prepaid and Other Current Assets

Interest receivable

$

1,843

$

337

Prepaid research and development manufacturing expenses

2,919

599

Prepaid insurance

394

138

Other

 

575

 

353

$

5,731

$

1,427

Property and Equipment

Laboratory equipment

$

2,996

$

2,646

Computer equipment and purchased software

 

212

 

190

Leasehold improvements

 

33

 

33

Construction in progress

300

 

3,541

 

2,869

Less: accumulated depreciation and amortization

 

(2,711)

 

(2,649)

$

830

$

220

Accrued and Other Liabilities

Accrued clinical trial expense

$

3,652

$

3,566

Accrued manufacturing expense

 

3,032

 

1,812

Personnel related

 

1,932

 

641

Accrued legal and accounting

256

229

Other

 

299

 

238

$

9,171

$

6,486

During the three months ended June 30, 2026 and 2025, the Company recorded approximately $34,000 and $29,000 in depreciation expense, respectively, and during the six months ended June 30, 2026 and 2025, the Company recorded approximately $63,000 and $51,000 in depreciation expense, respectively.